The trajectory of the erectile dysfunction drug presents a complex picture for those considering investment. While the initial introduction generated massive returns, the end of its intellectual property protection https://wise-social.com/story7209063/sildenafil-and-the-pharmaceutical-industry-a-volatile-opportunity